Compare AANJANEYA LIFECARE with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ALKEM LABORATORIES DR. DATSONS LABS/
ALKEM LABORATORIES
 
P/E (TTM) x -10.9 22.0 - View Chart
P/BV x 0.2 5.3 3.1% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 DR. DATSONS LABS   ALKEM LABORATORIES
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ALKEM LABORATORIES
Mar-20
DR. DATSONS LABS/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1262,720 4.6%   
Low Rs311,660 1.9%   
Sales per share (Unadj.) Rs133.0697.9 19.1%  
Earnings per share (Unadj.) Rs0.296.1 0.2%  
Cash flow per share (Unadj.) Rs6.6117.3 5.6%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs128.8515.2 25.0%  
Shares outstanding (eoy) m31.66119.57 26.5%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.1 18.7%   
Avg P/E ratio x516.122.8 2,265.1%  
P/CF ratio (eoy) x11.818.7 63.4%  
Price / Book Value ratio x0.64.3 14.3%  
Dividend payout %026.0 0.0%   
Avg Mkt Cap Rs m2,477261,879 0.9%   
No. of employees `000NA14.3 0.0%   
Total wages/salary Rs m5615,055 0.4%   
Avg. sales/employee Rs ThNM5,822.6-  
Avg. wages/employee Rs ThNM1,050.5-  
Avg. net profit/employee Rs ThNM802.0-  
INCOME DATA
Net Sales Rs m4,21183,444 5.0%  
Other income Rs m791,042 7.6%   
Total revenues Rs m4,28984,486 5.1%   
Gross profit Rs m56914,734 3.9%  
Depreciation Rs m2042,528 8.1%   
Interest Rs m430651 66.1%   
Profit before tax Rs m1312,598 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,105 0.6%   
Profit after tax Rs m511,493 0.0%  
Gross profit margin %13.517.7 76.5%  
Effective tax rate %48.08.8 547.7%   
Net profit margin %0.113.8 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,85254,960 12.5%   
Current liabilities Rs m6,71132,433 20.7%   
Net working cap to sales %3.327.0 12.4%  
Current ratio x1.01.7 60.3%  
Inventory Days Days16180 202.2%  
Debtors Days Days31872 441.4%  
Net fixed assets Rs m3,67332,710 11.2%   
Share capital Rs m317239 132.4%   
"Free" reserves Rs m3,76161,368 6.1%   
Net worth Rs m4,07861,607 6.6%   
Long term debt Rs m1,6711,592 104.9%   
Total assets Rs m12,63399,433 12.7%  
Interest coverage x1.020.4 5.1%   
Debt to equity ratio x0.40 1,585.3%  
Sales to assets ratio x0.30.8 39.7%   
Return on assets %3.412.2 28.2%  
Return on equity %0.118.7 0.6%  
Return on capital %7.721.0 36.6%  
Exports to sales %22.919.1 120.0%   
Imports to sales %14.33.0 480.4%   
Exports (fob) Rs m96415,917 6.1%   
Imports (cif) Rs m6022,483 24.2%   
Fx inflow Rs m96416,061 6.0%   
Fx outflow Rs m6072,483 24.5%   
Net fx Rs m35713,578 2.6%   
CASH FLOW
From Operations Rs m1,3455,851 23.0%  
From Investments Rs m-2,256-7,414 30.4%  
From Financial Activity Rs m-1,200792 -151.6%  
Net Cashflow Rs m-2,111-731 288.7%  

Share Holding

Indian Promoters % 4.5 66.9 6.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 33.1 -  
FIIs % 1.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 0.0 -  
Shareholders   20,807 68,381 30.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   J.B.CHEMICALS  DR. REDDYS LAB  GSK PHARMA  SUVEN LIFE SCIENCES  PROCTER & GAMBLE HEALTH  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS